Herlyn, Meenhard F
- University of Pennsylvania · Pathology (NIH department code)
- NYU Grossman School of Medicine · Dermatology (NIH department code)
- University of Pennsylvania · Genetics (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,720
- Rising Star
- R01 Holder
- Translational
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2020 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pathology
- Dermatology
- Genetics
NIH Funding · FY2023
Linked Award Amount
$2M
Full award amounts, FY2023
Award Records
5
Records listing this PI
Award-Linked Rank
#3,720
By linked amount among FY2023 PIs
Earliest Year Loaded
2020
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Herlyn, Meenhard F as a PI. Multi-PI records show the full award amount for context.
- 5R01CA258113-02R01Contact PIGamma delta T cell based melanoma therapiesUniversity of Pennsylvania · Pathology (NIH department code)$632.7Kaward amount
- 5R01CA259295-02R01Contact PIDissecting Phenotype Switching in Early Stage MelanomasNYU Grossman School of Medicine · Dermatology (NIH department code)$612.9Kaward amount
- 5R01CA238237-04R01Contact PIUnderstanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in MelanomaUniversity of Pennsylvania · Genetics (NIH department code)$493.8Kaward amount
- 3R01CA258113-02S1R01Contact PIExplore Gamma delta T cell-based glioblastoma therapiesUniversity of Pennsylvania · Pathology (NIH department code)$158.8Kaward amount
- 3R01CA238237-04S1R01Contact PIUnderstanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in MelanomaUniversity of Pennsylvania · Genetics (NIH department code)$116.7Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Herlyn, Meenhard F as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2020First NIH AwardUniversity of Pennsylvania
- 2020$500K Cumulative Funding
- 2020Entered Top 50% NationallyRanked #9645
- 2021$1M Cumulative Funding
- 2021Multi-Institutional ResearchAwards at 2 institutions
- 2021R01 Grant Holder
- 2022$2M Cumulative Funding
- 2023Entered Top 25% NationallyRanked #3720